248 related articles for article (PubMed ID: 3861180)
1. Recombinant human interferon sensitizes resistant myeloid leukemic cells to induction of terminal differentiation.
Grant S; Bhalla K; Weinstein B; Pestka S; Mileno MD; Fisher PB
Biochem Biophys Res Commun; 1985 Jul; 130(1):379-88. PubMed ID: 3861180
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human interferon alpha enhancement of retinoic-acid-induced differentiation of HL-60 cells.
Kohlhepp EA; Condon ME; Hamburger AW
Exp Hematol; 1987 May; 15(4):414-8. PubMed ID: 3471521
[TBL] [Abstract][Full Text] [Related]
3. Characterization of differentiation-inducer-resistant HL-60 cells.
Gallagher RE; Bilello PA; Ferrari AC; Chang CS; Yen RW; Nickols WA; Muly EC
Leuk Res; 1985; 9(8):967-86. PubMed ID: 3862924
[TBL] [Abstract][Full Text] [Related]
4. Changes in binding of alpha interferon IFN-alpha A to HL-60 cells during myeloid differentiation.
Langer JA; Pestka S
J Interferon Res; 1985; 5(4):637-49. PubMed ID: 3866800
[TBL] [Abstract][Full Text] [Related]
5. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
[TBL] [Abstract][Full Text] [Related]
6. Effects of interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cells from acute myelogenous leukemia patients treated with recombinant leukocyte-alpha A interferon.
Gallagher RE; Lurie KJ; Leavitt RD; Wiernik PH
Leuk Res; 1987; 11(7):609-19. PubMed ID: 3475513
[TBL] [Abstract][Full Text] [Related]
7. Resistance of HL-60 promyelocytic leukemia cells to induction of differentiation and its reversal by combination treatment.
Schwartsmann G; Pinedo HM; Leyva A
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):739-43. PubMed ID: 2443360
[TBL] [Abstract][Full Text] [Related]
8. The effect of glutathione on HL-60 treated with dimethylsulfoxide, butyric acid or 12-O-tetradecanoylphorbol-13-acetate.
Zucker RM; Whittington KB; Decal DL
FEBS Lett; 1983 May; 155(1):107-12. PubMed ID: 6573264
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
Makishima M; Kanatani Y; Yamamoto-Yamaguchi Y; Honma Y
Blood; 1996 Apr; 87(8):3384-94. PubMed ID: 8605356
[TBL] [Abstract][Full Text] [Related]
10. Functional and phenotypic characterization of two HL60 clones resistant to dimethylsulfoxide.
Ferrero D; Gallo E; Lanfrancone L; Tarella C
Exp Cell Res; 1983 Aug; 147(1):111-8. PubMed ID: 6578050
[TBL] [Abstract][Full Text] [Related]
11. Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines.
Kaplinsky C; Estrov Z; Freedman MH; Cohen A
Blood Cells; 1986; 11(3):459-68. PubMed ID: 3461855
[TBL] [Abstract][Full Text] [Related]
12. Effects of interferon on differentiation of normal and tumor cells.
Fisher PB; Grant S
Pharmacol Ther; 1985; 27(2):143-66. PubMed ID: 2412243
[TBL] [Abstract][Full Text] [Related]
13. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
Herwig S; Su Q; Zhang W; Ma Y; Tempst P
Blood; 1996 Jan; 87(1):350-64. PubMed ID: 8547662
[TBL] [Abstract][Full Text] [Related]
14. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
15. Effects of simultaneous and sequential exposure to granulocytic and monocytic inducers on the choice of differentiation pathway in HL-60 promyelocytic leukemia cells.
Zinzar S; Ohnuma T; Holland JF
Leuk Res; 1989; 13(1):23-30. PubMed ID: 2915572
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of human beta-interferon for differentiating leukemic HL-60 cells.
Hamburger AW; White CP; Siebenlist RE; Sedmak JJ; Grossberg SE
Cancer Res; 1985 Nov; 45(11 Pt 1):5369-73. PubMed ID: 2996760
[TBL] [Abstract][Full Text] [Related]
17. Induction of differentiation of human myeloid leukemias: surface changes probed with monoclonal antibodies.
Ferrero D; Pessano S; Pagliardi GL; Rovera G
Blood; 1983 Jan; 61(1):171-9. PubMed ID: 6571714
[TBL] [Abstract][Full Text] [Related]
18. In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic cells.
Tobler A; Munker R; Heitjan D; Koeffler HP
Blood; 1987 Dec; 70(6):1940-6. PubMed ID: 2823943
[TBL] [Abstract][Full Text] [Related]
19. Expression of granulocytic functions by leukemic promyelocytic HL-60 cells: differential induction by dimethylsulfoxide and retinoic acid.
Matzner Y; Gavison R; Rachmilewitz EA; Fibach E
Cell Differ; 1987 Sep; 21(4):261-9. PubMed ID: 3476206
[TBL] [Abstract][Full Text] [Related]
20. [Decrease of insulin binding to human acute leukemic cells during chemically induced differentiation].
Palumbo A; Turco GL; Brossa C; D'Alberto M; Ghezzo F; Pegoraro L
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1350-4. PubMed ID: 7004463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
